Consensus Statements

News and Upcoming Activities - Consensus Statements - Technology Assessment Statements - About the Consensus Program - CME Online - Search



Related Conference Materials
   Program & Abstracts (PDF file, 1.2 MB)
   NLM Bibliography
   News Release
   CME Online
   List of Publications Related to this Consensus Conference

Genetic Testing for Cystic Fibrosis
April 14-16, 1997
Vol. 15, No. 4


Genetic testing for CF should be offered to adults with a positive family history of CF, to partners of people with CF, to couples currently planning a pregnancy, and to couples seeking prenatal care. The panel does not recommend offering CF genetic testing to the general population or newborn infants. The panel advocates active research to develop improved treatments for people with CF and continued investigation into the understanding of the pathophysiology of the disease. Comprehensive educational programs targeted to health care professionals and the public should be developed using input from people living with CF and their families and from people from diverse racial and ethnic groups. Additionally, genetic counseling services must be accurate and provide balanced information to afford individuals the opportunity to make autonomous decisions. Every attempt should be made to protect individual rights, genetic and medical privacy rights, and to prevent discrimination and stigmatization. It is essential that the offering of CF carrier testing be phased in over a period of time to ensure that adequate education and appropriate genetic testing and counseling services are available to all persons being tested.

Read full NIH Consensus Statement

Download full NIH Consensus Statement (PDF file, 352K)


NOTE:

NIH Consensus Statements are prepared by a nonadvocate, non-Federal panel of experts, based on (1) presentations by investigators working in areas relevant to the consensus questions during a 2-day public session; (2) questions and statements from conference attendees during open discussion periods that are part of the public session; and (3) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.

The statement reflects the panel’s assessment of medical knowledge available at the time the statement was written. Thus, it provides a "snapshot in time" of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.

Go to:


NIH - Consensus Page - NLM HSTAT

NIH Home Page | Consensus Page | NLM HSTAT Home Page